The relationship of asthma medication use to perinatal outcomes

Michael Schatz, Mitchell P. Dombrowski, Robert Wise, Valerija Momirova, Mark Landon, William Mabie, Roger B. Newman, John C. Hauth, Marshall Lindheimer, Steve N. Caritis, Kenneth J. Leveno, Paul Meis, Menachem Miodovnik, Ronald J. Wapner, Richard H. Paul, Michael W. Varner, Mary Jo O'Sullivan, Gary R. Thurnau, Deborah L. Conway

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

Background Maternal asthma has been reported to increase the risk of preeclampsia, preterm deliveries, and lower-birth-weight infants, but the mechanisms of this effect are not defined. Objective We sought to evaluate the relationship between the use of contemporary asthma medications and adverse perinatal outcomes. Methods Asthmatic patients were recruited from the 16 centers of the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network from December 1994 through February 2000. Gestational medication use was determined on the basis of patient history at enrollment and at monthly visits during pregnancy. Perinatal data were obtained at postpartum chart reviews. Perinatal outcome variables included gestational hypertension, preterm births, low-birth-weight infants, small-for-gestational- age infants, and major malformations. Results The final cohort included 2123 asthmatic participants. No significant relationships were found between the use of inhaled β-agonists (n=1828), inhaled corticosteroids (n=722), or theophylline (n=273) and adverse perinatal outcomes. After adjusting for demographic and asthma severity covariates, oral corticosteroid use was significantly associated with both preterm birth at less than 37 weeks' gestation (odds ratio, 1.54; 95% CI, 1.02-2.33) and low birth weight of less than 2500 g (odds ratio, 1.80; 95% CI, 1.13-2.88). Conclusions Use of inhaled β-agonists, inhaled steroids, and theophylline do not appear to increase perinatal risks in pregnant asthmatic women. The mechanism of the association between maternal oral corticosteroid use and prematurity remains to be determined.

Original languageEnglish
Pages (from-to)1040-1045
Number of pages6
JournalJournal of Allergy and Clinical Immunology
Volume113
Issue number6
DOIs
StatePublished - Jun 1 2004
Externally publishedYes

Fingerprint

Adrenal Cortex Hormones
Asthma
Premature Birth
Mothers
Low Birth Weight Infant
Theophylline
Odds Ratio
National Institute of Child Health and Human Development (U.S.)
Small for Gestational Age Infant
Pregnancy
Pregnancy Induced Hypertension
Pre-Eclampsia
Birth Weight
Postpartum Period
Pregnant Women
Steroids
Medicine
Demography

Keywords

  • Asthma
  • asthma medications
  • inhaled β-agonists
  • inhaled corticosteroids
  • Maternal Fetal Medicine Units
  • MFMU
  • National Institute of Child Health and Human Development
  • NICHD
  • oral corticosteroids
  • perinatal outcomes
  • pregnancy
  • prematurity
  • theophylline

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Schatz, M., Dombrowski, M. P., Wise, R., Momirova, V., Landon, M., Mabie, W., ... Conway, D. L. (2004). The relationship of asthma medication use to perinatal outcomes. Journal of Allergy and Clinical Immunology, 113(6), 1040-1045. https://doi.org/10.1016/j.jaci.2004.03.017

The relationship of asthma medication use to perinatal outcomes. / Schatz, Michael; Dombrowski, Mitchell P.; Wise, Robert; Momirova, Valerija; Landon, Mark; Mabie, William; Newman, Roger B.; Hauth, John C.; Lindheimer, Marshall; Caritis, Steve N.; Leveno, Kenneth J.; Meis, Paul; Miodovnik, Menachem; Wapner, Ronald J.; Paul, Richard H.; Varner, Michael W.; O'Sullivan, Mary Jo; Thurnau, Gary R.; Conway, Deborah L.

In: Journal of Allergy and Clinical Immunology, Vol. 113, No. 6, 01.06.2004, p. 1040-1045.

Research output: Contribution to journalArticle

Schatz, M, Dombrowski, MP, Wise, R, Momirova, V, Landon, M, Mabie, W, Newman, RB, Hauth, JC, Lindheimer, M, Caritis, SN, Leveno, KJ, Meis, P, Miodovnik, M, Wapner, RJ, Paul, RH, Varner, MW, O'Sullivan, MJ, Thurnau, GR & Conway, DL 2004, 'The relationship of asthma medication use to perinatal outcomes', Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1040-1045. https://doi.org/10.1016/j.jaci.2004.03.017
Schatz M, Dombrowski MP, Wise R, Momirova V, Landon M, Mabie W et al. The relationship of asthma medication use to perinatal outcomes. Journal of Allergy and Clinical Immunology. 2004 Jun 1;113(6):1040-1045. https://doi.org/10.1016/j.jaci.2004.03.017
Schatz, Michael ; Dombrowski, Mitchell P. ; Wise, Robert ; Momirova, Valerija ; Landon, Mark ; Mabie, William ; Newman, Roger B. ; Hauth, John C. ; Lindheimer, Marshall ; Caritis, Steve N. ; Leveno, Kenneth J. ; Meis, Paul ; Miodovnik, Menachem ; Wapner, Ronald J. ; Paul, Richard H. ; Varner, Michael W. ; O'Sullivan, Mary Jo ; Thurnau, Gary R. ; Conway, Deborah L. / The relationship of asthma medication use to perinatal outcomes. In: Journal of Allergy and Clinical Immunology. 2004 ; Vol. 113, No. 6. pp. 1040-1045.
@article{9d2fc3f2d0a44c7fb03b76e4bb12df31,
title = "The relationship of asthma medication use to perinatal outcomes",
abstract = "Background Maternal asthma has been reported to increase the risk of preeclampsia, preterm deliveries, and lower-birth-weight infants, but the mechanisms of this effect are not defined. Objective We sought to evaluate the relationship between the use of contemporary asthma medications and adverse perinatal outcomes. Methods Asthmatic patients were recruited from the 16 centers of the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network from December 1994 through February 2000. Gestational medication use was determined on the basis of patient history at enrollment and at monthly visits during pregnancy. Perinatal data were obtained at postpartum chart reviews. Perinatal outcome variables included gestational hypertension, preterm births, low-birth-weight infants, small-for-gestational- age infants, and major malformations. Results The final cohort included 2123 asthmatic participants. No significant relationships were found between the use of inhaled β-agonists (n=1828), inhaled corticosteroids (n=722), or theophylline (n=273) and adverse perinatal outcomes. After adjusting for demographic and asthma severity covariates, oral corticosteroid use was significantly associated with both preterm birth at less than 37 weeks' gestation (odds ratio, 1.54; 95{\%} CI, 1.02-2.33) and low birth weight of less than 2500 g (odds ratio, 1.80; 95{\%} CI, 1.13-2.88). Conclusions Use of inhaled β-agonists, inhaled steroids, and theophylline do not appear to increase perinatal risks in pregnant asthmatic women. The mechanism of the association between maternal oral corticosteroid use and prematurity remains to be determined.",
keywords = "Asthma, asthma medications, inhaled β-agonists, inhaled corticosteroids, Maternal Fetal Medicine Units, MFMU, National Institute of Child Health and Human Development, NICHD, oral corticosteroids, perinatal outcomes, pregnancy, prematurity, theophylline",
author = "Michael Schatz and Dombrowski, {Mitchell P.} and Robert Wise and Valerija Momirova and Mark Landon and William Mabie and Newman, {Roger B.} and Hauth, {John C.} and Marshall Lindheimer and Caritis, {Steve N.} and Leveno, {Kenneth J.} and Paul Meis and Menachem Miodovnik and Wapner, {Ronald J.} and Paul, {Richard H.} and Varner, {Michael W.} and O'Sullivan, {Mary Jo} and Thurnau, {Gary R.} and Conway, {Deborah L.}",
year = "2004",
month = "6",
day = "1",
doi = "10.1016/j.jaci.2004.03.017",
language = "English",
volume = "113",
pages = "1040--1045",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - The relationship of asthma medication use to perinatal outcomes

AU - Schatz, Michael

AU - Dombrowski, Mitchell P.

AU - Wise, Robert

AU - Momirova, Valerija

AU - Landon, Mark

AU - Mabie, William

AU - Newman, Roger B.

AU - Hauth, John C.

AU - Lindheimer, Marshall

AU - Caritis, Steve N.

AU - Leveno, Kenneth J.

AU - Meis, Paul

AU - Miodovnik, Menachem

AU - Wapner, Ronald J.

AU - Paul, Richard H.

AU - Varner, Michael W.

AU - O'Sullivan, Mary Jo

AU - Thurnau, Gary R.

AU - Conway, Deborah L.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Background Maternal asthma has been reported to increase the risk of preeclampsia, preterm deliveries, and lower-birth-weight infants, but the mechanisms of this effect are not defined. Objective We sought to evaluate the relationship between the use of contemporary asthma medications and adverse perinatal outcomes. Methods Asthmatic patients were recruited from the 16 centers of the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network from December 1994 through February 2000. Gestational medication use was determined on the basis of patient history at enrollment and at monthly visits during pregnancy. Perinatal data were obtained at postpartum chart reviews. Perinatal outcome variables included gestational hypertension, preterm births, low-birth-weight infants, small-for-gestational- age infants, and major malformations. Results The final cohort included 2123 asthmatic participants. No significant relationships were found between the use of inhaled β-agonists (n=1828), inhaled corticosteroids (n=722), or theophylline (n=273) and adverse perinatal outcomes. After adjusting for demographic and asthma severity covariates, oral corticosteroid use was significantly associated with both preterm birth at less than 37 weeks' gestation (odds ratio, 1.54; 95% CI, 1.02-2.33) and low birth weight of less than 2500 g (odds ratio, 1.80; 95% CI, 1.13-2.88). Conclusions Use of inhaled β-agonists, inhaled steroids, and theophylline do not appear to increase perinatal risks in pregnant asthmatic women. The mechanism of the association between maternal oral corticosteroid use and prematurity remains to be determined.

AB - Background Maternal asthma has been reported to increase the risk of preeclampsia, preterm deliveries, and lower-birth-weight infants, but the mechanisms of this effect are not defined. Objective We sought to evaluate the relationship between the use of contemporary asthma medications and adverse perinatal outcomes. Methods Asthmatic patients were recruited from the 16 centers of the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network from December 1994 through February 2000. Gestational medication use was determined on the basis of patient history at enrollment and at monthly visits during pregnancy. Perinatal data were obtained at postpartum chart reviews. Perinatal outcome variables included gestational hypertension, preterm births, low-birth-weight infants, small-for-gestational- age infants, and major malformations. Results The final cohort included 2123 asthmatic participants. No significant relationships were found between the use of inhaled β-agonists (n=1828), inhaled corticosteroids (n=722), or theophylline (n=273) and adverse perinatal outcomes. After adjusting for demographic and asthma severity covariates, oral corticosteroid use was significantly associated with both preterm birth at less than 37 weeks' gestation (odds ratio, 1.54; 95% CI, 1.02-2.33) and low birth weight of less than 2500 g (odds ratio, 1.80; 95% CI, 1.13-2.88). Conclusions Use of inhaled β-agonists, inhaled steroids, and theophylline do not appear to increase perinatal risks in pregnant asthmatic women. The mechanism of the association between maternal oral corticosteroid use and prematurity remains to be determined.

KW - Asthma

KW - asthma medications

KW - inhaled β-agonists

KW - inhaled corticosteroids

KW - Maternal Fetal Medicine Units

KW - MFMU

KW - National Institute of Child Health and Human Development

KW - NICHD

KW - oral corticosteroids

KW - perinatal outcomes

KW - pregnancy

KW - prematurity

KW - theophylline

UR - http://www.scopus.com/inward/record.url?scp=3042792754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042792754&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2004.03.017

DO - 10.1016/j.jaci.2004.03.017

M3 - Article

C2 - 15208581

AN - SCOPUS:3042792754

VL - 113

SP - 1040

EP - 1045

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 6

ER -